| A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer (NCT05055323) | Thomas Jefferson University | 2021-07-29 |
| Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose) (NCT04993586) | AnGes, Inc. | 2021-07-29 |
| Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy (NCT05075603) | NeoImmuneTech | 2021-07-29 |
| Clinical Study of JS201 in Patients With Advanced Malignant Tumors (NCT04956926) | Shanghai Junshi Bioscience Co., Ltd. | 2021-07-29 |
| SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot (NCT04907214) | Vanderbilt University Medical Center | 2021-07-29 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM (NCT07217184) | GlaxoSmithKline | 2021-07-29 |
| Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants (NCT04991571) | AstraZeneca | 2021-07-29 |
| Comparison of Blood Levels of HTL0016878 From an Oral Capsule and an Oral Solution (NCT04935320) | Nxera Pharma UK Limited | 2021-07-29 |
| Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG) (NCT04804709) | Columbia University | 2021-07-28 |
| Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration (NCT05005884) | Shahid Beheshti University of Medical Sciences | 2021-07-28 |
| Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma (NCT04983407) | Aravive, Inc. | 2021-07-28 |
| Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998) (NCT05004415) | Atea Pharmaceuticals, Inc. | 2021-07-28 |
| A Study of CC-90011 and Comparators in Participants With Prostate Cancer (NCT04628988) | Celgene | 2021-07-28 |
| A Study to Determine the Absolute Bioavailability of BIIB122/DNL151 in Healthy Subjects (NCT05005338) | Biogen | 2021-07-28 |
| A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2) (NCT05797701) | Sanofi | 2021-07-28 |
| A Study of CN1 in Combination With CN401 in Adult Patients With Relapsed/Refractory Lymphoid Malignancies (NCT04880564) | Curon Biopharmaceutical (Australia) Co Pty Ltd | 2021-07-28 |
| A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants (NCT04956627) | Bristol-Myers Squibb | 2021-07-28 |
| Multi-intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Heart Failure With Reduced Ejection Fraction（PRIME-HFrEF Study） (NCT04992832) | Shanghai East Hospital | 2021-07-28 |
| Role of L-citrulline in Prevention of Pregnancy Associated Hypertension (NCT04979793) | The University of Texas Medical Branch, Galveston | 2021-07-28 |
| ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer (NCT04602117) | QuantumLeap Healthcare Collaborative | 2021-07-28 |
| A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC (NCT04849273) | Turning Point Therapeutics, Inc. | 2021-07-28 |
| Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer (NCT05016544) | Sun Yat-sen University | 2021-07-28 |
| Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration (NCT04989699) | Ocular Therapeutix, Inc. | 2021-07-28 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231 in Healthy Adults (NCT04916431) | ModernaTX, Inc. | 2021-07-28 |
| Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) (NCT04975256) | Mirati Therapeutics Inc. | 2021-07-28 |
| A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL (NCT04876092) | Janssen Research & Development, LLC | 2021-07-28 |
| A Study to Evaluate the Safety and Effect of STC314 Injection Continuous Infusion in Subjects With Acute Respiratory Distress Syndrome (NCT05000671) | Grand Medical Pty Ltd. | 2021-07-28 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a) (NCT04987320) | Amgen | 2021-07-28 |
| Safety and Efficacy of BC LisPram (NCT04972175) | Michael Tsoukas | 2021-07-28 |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients (NCT05273944) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2021-07-28 |
| RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy (NCT05044598) | University College, London | 2021-07-28 |
| A Study of LY3361237 in Participants With Psoriasis (NCT04975295) | Eli Lilly and Company | 2021-07-27 |
| A Trial of SHR-1905 in Healthy Subjects (NCT04800263) | Atridia Pty Ltd. | 2021-07-27 |
| Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE) (NCT05001698) | AstraZeneca | 2021-07-27 |
| Phase 1 Study of 3D229 in Healthy Subjects (NCT04941313) | 3D Medicines | 2021-07-27 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers (NCT04994106) | AstraZeneca | 2021-07-27 |
| Propranolol for Protracted Labor (NCT04741698) | Christiana Care Health Services | 2021-07-27 |
| Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection (NCT04834908) | Bharat Serums and Vaccines Limited | 2021-07-27 |
| CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL (NCT04995536) | City of Hope Medical Center | 2021-07-27 |
| A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (NCT04910568) | Genentech, Inc. | 2021-07-26 |
| ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) (NCT04669587) | EnhancedBio USA Inc. | 2021-07-26 |
| A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours (NCT04823897) | PharmaMatrix Holdings Ltd | 2021-07-26 |
| A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors (NCT04843709) | Lepu Biopharma Co., Ltd. | 2021-07-26 |
| A Study of TAK-105 in Healthy Adults (NCT04964258) | Takeda | 2021-07-26 |
| A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID) (NCT04880161) | Ampio Pharmaceuticals. Inc. | 2021-07-26 |
| Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults (NCT04940845) | Shanghai Hansoh Biomedical Co., Ltd | 2021-07-26 |
| Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants (NCT04944771) | AstraZeneca | 2021-07-26 |
| A Phase 1 Study of SSS17 in Healthy Subjects. (NCT04893187) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2021-07-26 |
| A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in China (NCT05009329) | Allist Pharmaceuticals, Inc. | 2021-07-26 |
| Understanding Ketamine's Dissociative Effects (KD Study) (NCT04861051) | Stanford University | 2021-07-26 |
| A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue (NCT04141696) | National Institute of Nursing Research (NINR) | 2021-07-26 |
| FTIH Study of ECC0509 in Healthy Volunteers (NCT05012423) | Eccogene | 2021-07-26 |
| To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects (NCT06468579) | Suzhou Kintor Pharmaceutical Inc, | 2021-07-25 |
| A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects (NCT05012436) | Yuhan Corporation | 2021-07-24 |
| Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics (NCT04933383) | Aquilon Pharmaceuticals S.A. | 2021-07-23 |
| A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers (NCT05002244) | Celltrion | 2021-07-23 |
| A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62 (NCT05409027) | Sparrow Pharmaceuticals | 2021-07-23 |
| IBI310 in Combination With Siltilimab in Subjects With Anti-PD-1/PD-L1 Resistance R/M NPC (NCT04945421) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-07-23 |
| Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer (NCT04878029) | Emory University | 2021-07-23 |
| A Study in Healthy Humans to Assess the Relative Bioavailability of One Fixed-dose Combination Tablet Empagliflozin/Metformin Versus Jardiance® Tablet and Glifage® Tablet Administered Together (NCT05083949) | Boehringer Ingelheim | 2021-07-23 |
| Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy Adults (NCT05490095) | Sovargen | 2021-07-23 |
| To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers (NCT04888715) | Daewoong Pharmaceutical Co. LTD. | 2021-07-23 |
| A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants (NCT05909852) | Amgen | 2021-07-23 |
| Phase I/II Clinical Trial Stem Cell Gene Therapy in RAG1-Deficient SCID (NCT04797260) | Videja B.V. | 2021-07-23 |
| A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers (NCT05009368) | Celltrion | 2021-07-23 |
| Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors (NCT04750954) | National Cancer Institute (NCI) | 2021-07-22 |
| First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers. (NCT05016687) | Curovir AB | 2021-07-22 |
| Investigation of the Pharmacokinetic Profile of CBD - Phase 1 ANANDA (NCT05023070) | Icahn School of Medicine at Mount Sinai | 2021-07-22 |
| A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects. (NCT04808154) | Sinew Pharma Inc. | 2021-07-22 |
| Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder (NCT04987658) | Alkermes, Inc. | 2021-07-22 |
| SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD) (NCT04381468) | Vaccinex Inc. | 2021-07-22 |
| CNS10-NPC for the Treatment of RP (NCT04284293) | Cedars-Sinai Medical Center | 2021-07-22 |
| Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss (NCT04766853) | Seoul National University Hospital | 2021-07-22 |
| Study of RP-3500 (Camonsertib) With Niraparib or Olaparib in Advanced Solid Tumors (NCT04972110) | Repare Therapeutics | 2021-07-21 |
| Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056 (NCT04771143) | Novartis Pharmaceuticals | 2021-07-21 |
| A Study in Healthy Men to Test How BI 474121 is Tolerated (NCT04964453) | Boehringer Ingelheim | 2021-07-21 |
| A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBC (NCT05103917) | Abbisko Therapeutics Co, Ltd | 2021-07-21 |
| Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults (NCT04672291) | Oncovir, Inc. | 2021-07-21 |
| A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid Tumors (NCT05329298) | Betta Pharmaceuticals Co., Ltd. | 2021-07-21 |
| IBI322 Monotherapy or Combination Therapy in Subjects With Advanced Malignant Tumors. (NCT04912466) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-07-21 |
| Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas (NCT05101148) | AstraZeneca | 2021-07-21 |
| A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment (NCT05673603) | Insmed Incorporated | 2021-07-20 |
| A First-in-Human Study of SBP-9330 in Healthy Subjects (NCT04948827) | Camino Pharma, LLC | 2021-07-20 |
| Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants (NCT04962022) | Pfizer | 2021-07-20 |
| A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NCT05149391) | Peking University | 2021-07-20 |
| A Study to Evaluate How Well Single and Multiple Doses of GLPG3667 Are Tolerated in Healthy, Adult Subjects (NCT04976270) | Lakefront Biotherapeutics NV | 2021-07-20 |
| Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk (NCT04431960) | University of Connecticut | 2021-07-20 |
| Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage) (NCT05507762) | Renmin Hospital of Wuhan University | 2021-07-20 |
| A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants (NCT04949269) | Bristol-Myers Squibb | 2021-07-20 |
| PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD) (NCT04582916) | National Institute of Mental Health (NIMH) | 2021-07-20 |
| Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors (NCT04901806) | Pyramid Biosciences | 2021-07-20 |
| A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication (NCT04937829) | Boehringer Ingelheim | 2021-07-20 |
| Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies (NCT05391022) | Constellation Pharmaceuticals | 2021-07-20 |
| Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers (NCT04952506) | Chong Kun Dang Pharmaceutical | 2021-07-19 |
| Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects (NCT04971746) | Lakefront Biotherapeutics NV | 2021-07-19 |
| Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (NCT04789408) | Kite, A Gilead Company | 2021-07-19 |
| A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma (NCT04990037) | Cantargia AB | 2021-07-19 |
| Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine. (NCT05156723) | St. Petersburg Research Institute of Vaccines and Sera | 2021-07-19 |
| Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies. (NCT04775745) | Newave Pharmaceutical Inc | 2021-07-19 |
| Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants (NCT04978298) | Celgene | 2021-07-19 |